Man Group’s Adaptimmune Therapeutics ADAP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
2021
Q4
$508K Sell
2021
Q3
$767K Buy
2021
Q2
$438K Sell
2021
Q1
$718K Buy
2020
Q4
$558K Buy
2020
Q3
$588K Buy
2020
Q2
$372K Buy
2020
Q1
$92K Sell
2019
Q4
$1.3M Sell
2019
Q3
$3.1M Buy
2019
Q2
$7.39M Buy
2019
Q1
$5.76M Buy
2018
Q4
$6M Buy
2018
Q3
$5.41M Buy